Dr. Euan Murray, PhD

Senior Scientist at Elasmogen

Speaker

Euan is a senior scientist at Elasmogen where he is involved in the development of advanced therapies for the treatment of immune-mediated inflammatory disease (IMID). Using Elasmogen’s proprietary soloMER® technology he is currently developing multi-functional products that have the potential to improve treatment outcomes for patients. Prior to joining Elasmogen he trained in both chemistry and biology before a research career focussing on antibody development. He spent time at Edinburgh University developing methods to investigate cancer cell signalling before moving to Aberdeen, and a commercial setting, working on a number of successful antibody generation programs. He joined Elasmogen in 2022 to work with the highly specific, high affinity single binding domain biologics, soloMERs.